​

Acrivon Therapeutics Ownership | Who Owns Acrivon Therapeutics?

OverviewForecastFinancialsChart

Acrivon Therapeutics Ownership Summary

Acrivon Therapeutics is owned by 36.95% institutional investors, 21.09% insiders, and 41.96% retail investors. Ra capital management is the largest institutional shareholder, holding 21.81% of ACRV shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 1.68% of its assets in Acrivon Therapeutics shares.

ACRV Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAcrivon Therapeutics36.95%21.09%41.96%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management8.34M21.81%$16.93M
Baker bros. advisors lp22.81K0.06%$46.30K
Strs ohio---
Dafna capital management---
Mirae asset global etfs---
Corton capital---
Gamma investing---
Ameritas investment partners---
Invesco---
New york state common retirement fund---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ra capital management8.34M0.28%$16.93M
Baker bros. advisors lp22.81K0.00%$46.30K
Strs ohio---
Dafna capital management---
Mirae asset global etfs---
Corton capital---
Gamma investing---
Ameritas investment partners---
Invesco---
New york state common retirement fund---

Top Buyers

HolderShares% AssetsChange
Ra capital management8.34M0.28%-
Sterling capital management---198.00
Russell investments group---223.00
Gamma investing---287.00
Amalgamated bank---378.00

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---5.36M
Dafna capital management---112.41K
Invesco---35.31K
Baker bros. advisors lp22.81K0.00%-30.08K
Bank of new york mellon---27.64K

Sold Out

HolderChange
Sterling capital management-198.00
Russell investments group-223.00
Gamma investing-287.00
Amalgamated bank-378.00
Deutsche bank ag\-541.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20254-93.10%14,129,412-38.60%361.01%--100.00%1-92.86%
Dec 31, 20245915.69%23,249,5511.26%611.68%3129.17%14-
Sep 30, 202451-22,960,755-2.09%601.43%24-31.43%14133.33%
Jun 30, 20245110.87%23,451,87853.83%641.43%3545.83%6-33.33%
Mar 31, 20244612.20%15,245,531-0.33%671.44%2433.33%9-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
HBM Healthcare Investments AG Ord527.15K1.68%-39.51K
Vanguard Total Stock Mkt Idx Inv412.43K1.32%-
Vanguard US Total Market Shares ETF387.41K1.24%-
Vanguard Institutional Extnd Mkt Idx Tr176.37K0.56%-
iShares Biotechnology ETF129.64K0.41%1.11K
Fidelity Small Cap Index129.48K0.41%-
iShares Russell 2000 Value ETF108.94K0.35%-
A4Investments SICAV SIF ACCI IlanaA2EURH84.78K0.27%30.72K
Fidelity Extended Market Index74.08K0.24%-193.00
Bridgeway Ultra-Small Company Market73.00K0.23%-

Recent Insider Transactions

DateNameRoleActivityValue
May 01, 2025PERCEPTIVE ADVISORS LLC-Sell$400.51K
Apr 30, 2025PERCEPTIVE ADVISORS LLC-Sell$617.41K
Apr 29, 2025PERCEPTIVE ADVISORS LLC-Sell$352.50K
Apr 25, 2025PERCEPTIVE ADVISORS LLC-Sell$2.06M
Apr 28, 2025PERCEPTIVE ADVISORS LLC-Sell$335.84K

Insider Transactions Trends

DateBuySell
2025 Q2-5
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q21-

ACRV Ownership FAQ

Who Owns Acrivon Therapeutics?

Acrivon Therapeutics shareholders are primarily institutional investors at 36.95%, followed by 21.09% insiders and 41.96% retail investors. The average institutional ownership in Acrivon Therapeutics's industry, Biotech Stocks , is 64.05%, which Acrivon Therapeutics falls below.

Who owns the most shares of Acrivon Therapeutics?

Acrivon Therapeutics’s largest shareholders are Ra capital management (8.34M shares, 21.81%), Baker bros. advisors lp (22.81K shares, 0.06%), and Strs ohio (0 shares, 0%). Together, they hold 21.87% of Acrivon Therapeutics’s total shares outstanding.

Does Blackrock own Acrivon Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Acrivon Therapeutics.

Who is Acrivon Therapeutics’s biggest shareholder by percentage of total assets invested?

Ra capital management is Acrivon Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.28% of its assets in 8.34M Acrivon Therapeutics shares, valued at 16.93M$.

Who is the top mutual fund holder of Acrivon Therapeutics shares?

HBM Healthcare Investments AG Ord is the top mutual fund holder of Acrivon Therapeutics shares, with 1.68% of its total shares outstanding invested in 527.15K Acrivon Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools